Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | Chief Financial Officer | $2.61M | +$25K | +0.97% | Jun 14, 2024 |
OPTN | OptiNose, Inc. | Chief Financial Officer | $163K | Mar 16, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|